Skip to content
HowShorted

Novavax, Inc. short interest in 2024

In 2024, Novavax, Inc.'s disclosed short interest ran from 42.86% of shares outstanding on 12 Jan 2024 to 23.05% on 31 Dec 2024, a change of -19.81 percentage points. The year's high was 46.15% on 15 Feb 2024 and its low 17.96% on 31 Jul 2024, averaging 28.13% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 13.59 days on 30 Apr 2024. Full history: Novavax, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Novavax, Inc. in 2024

2024 in figures

Start of year
42.86% (12 Jan 2024)
End of year
23.05% (31 Dec 2024)
Change
-19.81 pp
High
46.15% (15 Feb 2024)
Low
17.96% (31 Jul 2024)
Average
28.13%
Highest days to cover
13.59 (30 Apr 2024)
SEC filings marked
9

Every report in 2024

Novavax, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202442.86%4.95results (8-K)
31 Jan 202443.85%8.27
15 Feb 202446.15%8.10
29 Feb 202437.68%3.1010-K filed, results (8-K)
15 Mar 202434.39%6.08
28 Mar 202431.37%10.64
15 Apr 202431.27%11.16
30 Apr 202432.00%13.59
15 May 202432.26%1.2310-Q filed, results (8-K)
31 May 202427.22%2.30
14 Jun 202428.28%1.82
28 Jun 202421.03%2.78
15 Jul 202422.36%4.85
31 Jul 202417.96%3.09
15 Aug 202419.05%5.3510-Q filed, results (8-K)
30 Aug 202419.74%6.83
13 Sep 202420.94%5.18
30 Sep 202421.16%5.47
15 Oct 202422.31%5.51
31 Oct 202424.96%5.59
15 Nov 202425.91%6.0110-Q filed, results (8-K)
29 Nov 202424.84%9.77
13 Dec 202424.45%11.07
31 Dec 202423.05%11.49

See also: Novavax, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.